Home
,
Search
,
Index
,
Links
,
Pathology
,
Molecules
,
Syndromes
,
Muscle
,
NMJ
,
Nerve
,
Spinal
,
Ataxia
,
Antibody & Biopsy
,
Patient Info
Metabolic & Systemic Disorders
Endocrine
Hematologic
Hepatic
Renal
RENAL FAILURE
Polyneuropathy
Epidemiology
Frequency: 60% with at least subclinical neuropathy
Male > Female
Associated with glomerular filtration rate < 12 mL/min
Possible pathogenesis
Deficiencies:
Thiamine
, Biotin, Zinc deficiencies
Uremic toxins: "Middle molecules" (β2-microglobulin)
Associated medications: Colchicine; Nitrofurantoin; Alcohol
Clinical features
General
Distribution: Symmetric; Distal; Legs > Arms
More severe with long term dialysis
Sensory loss
Modalities: All (Large & Small fiber)
Distal > Proximal
Legs > Arms
Spontaneous sensations
Paresthesias & Dysesthesias: > 40%
Pain & Burning (Feet): 10%
Itch
Especially frequent with hemodialysis
Associated with presence of polyneuropathy
Motor: Weakness in patients with more severe neuropathy
Distal
Feet & Hands
Spontaneous activity
Cramps: 66%
Restless legs
Myokymia
Tendon reflexes: Reduced or Absent
Legs > Arms
Distal > Proximal
May be diffuse
Autonomic dysfunction: Mild
Loss of R-R interval variation
Sympathetic skin response: Abnormal in 45%
Course: Progression & resolution: Slow
Lab
CSF: Unremarkable
Electrophysiology
Mainly axonal loss: Low CMAP amplitudes
Mild slowing of NCVs
Not related to clinical signs
Correlates with creatinine clearance
Motor conduction velocity
May fall to 50% of mean control value
Peroneal correlates with creatinine clearance
Distal motor latencies: May be prolonged
SNAPs: Reduced amplitude
Nerve pathology
Distal axonal degeneration & loss
Axon size: May be reduced
Treatment
Renal transplantation
Improvement in most features
Little change in autonomic dysfunction
Dialysis: Stabilizes neuropathy
Rule out:
Additional drug toxicity
Amyloidosis
Mononeuropathy
Carpal tunnel syndrome
Associations: Vascular shunts; Amyloid
Often on side used in vascular access for dialysis
Chronic dialysis: Some evidence of CTS in 90%
Ulnar neuropathy
Ischemic arm neuropathies: Related to fistulas
Neuromuscular junction
Aminoglycoside toxicity
Myopathy
Disorders
Cachexia
Nephrotic syndrome
Inanition
Electrolyte disturbances
Hypercalcemia
Hyperkalemia
Common in: Endstage renal disease
4
Pathology: Membrane depolarization
Symptoms: Fatigue; Reduced endurance
EMG: Non-diagnostic; No spontaneous activity
NCV: Some patients have co-existing neuropathy
Hypermagnesemia
Disordered vitamin D metabolism: With bone disease
Muscle infarction 2° arterial calcification:
Calciphylaxis
Skin necrosis
Myopathy;
Rhabdomyolysis
Nephrogenic fibrosis
Drug toxicity
Aluminum
Laboratory
Serum CK: Usually normal, except some drug toxicity
Pathology:
Type II muscle fiber atrophy
Nephrogenic Fibrosis (Nephrogenic fibrosing dermopathy)
2
Epidemiology
Age: 4th to 6th decades
Sex: Males & Females affected
Cutaneous fibrosing disorder
Skin
Thickening & Hardening
Limbs: Usual
Legs: Most common; Distal > Proximal but sparing feet
Arms: Some patients; Distal or diffuse
Trunk: Occasional; Late
Face: Spared
Hyperpigmentation
Erythematous patches
Pain: Burning
Course: Progressive
Clinical: Other
Joints
Restriction of motion: Flexion contractures
Pain
Muscles
Hardening: Distal > Proximal
Skin changes over affected muscles
Strength: Normal
Neuropathy
Sensory: May be painful (Burning)
May be related to syndrome or renal disease
Eyes: Scleral injection
Associated disease
End-stage renal disease: Dialysis treatment; 2 to 7 years
Laboratory
Serum CK: Low (< 50)
Parathyroid hormone: Often high
Calcium-phosphate products: High
EMG: Myopathic changes
NCV: Reduced SNAP & CMAP amplitudes in most
Muscle MRI
High attenuation of fascial planes
Muscle signal: Patchy increase on T2 weighted image
Atrophy
Pathology: Skin
Dermal fibroblasts, spindle-shaped: Proliferation
Dendritic cells: Tissue accumulation
Collagen bundles: Thickened
Elastic fibers: Increased
Mucin deposition
Pathology: Muscle
Fibrosis: Perimysial (widening) > Endomysial
Myopathy: Varied muscle fiber size
Calcium deposition
Inflammation: Perimysium
Nephrogenic fibrosis: MRI
Subcutaneous tissue: Thickened
Muscles
Patchy high T2 signal
MRI shows changes in: Vastus lateralis (Large arrow) & Gracilis (Small arrow) on right
Fascial planes: Increased signal
HEPATIC DISORDERS
Demyelinating neuropathy
Sensory neuropathy with 1° biliary cirrhosis
Vitamin E deficiency
Childhood cholestatic disease
Hepatitis C
Navajo neuropathy with corneal ulceration
Hepatic myelopathy
Pruritis
Hepatic Demyelinating Neuropathy
Frequency: 50% to 70%
Usually subclinical
Distal; sensory
Autonomic: Usually parasympathetic, mild
Hepatic myelopathy
1
Associated with
Chronic liver disease
Acquired hepatocerebral degeneration: White matter enhancement on T2 MRI
Myelopathy
Spasticity: Legs > Arms
Tendon Reflexes: Brisk
Sensory: Normal
Bladder: Normal
Other CNS: Ataxia; Encephalopathy
Pathology: Pyramidal tract loss of myelinated axons
Hematologic Disorders
Myopathies +
5
Hemolytic Anemia
PFK deficiency
(GSD VII/Tarui): PFKM
GSD XII
: ALDOA
TPI deficiency
: TPI1
PGK deficiency
: PGK1
IPEX
: FOXP3
Immune:
LHIM
;
Jo-1
Sideroblastic anemia
Mitochondrial
MLASA1
: PUS1
MLASA2
: YARS2
MLASA3
: MT-ATP6
MC1DN30
: NDUFB11
Perrault 4
(HLASA): LARS2
Pearson Marrow-Pancreas syndrome
Also see
Mitochondrial disease + Anemia
Copper deficiency
Childhood-onset spasticity with hyperglycinemia
(SPAHGC): GLRX5
Sideroblastic anemia & Spinocerebellar ataxia
: ABCB7
Macrocytic anemia
COXPD 18
: SFXN4
ODOAD
: OPA1
Neutropenia
Barth
: TAZ
CNM1
: Dynamin 2
Eosinophilia
LGMD 2A
: CAPN3
Jordan anomaly
NLSD-M
: PNPLA2
NLSD-I
: ABHD5
Thrombocytopenia
Tubular Aggregate Myopathy 1
: STIM1
Tubular Aggregate Myopathy 2
: ORAI1
HIBM2
: GNE
Shwachman–Diamond
Pancytopenia
ATXPC
: SAM9DL
Acanthocytes
A-β-lipoproteinemia
: MTP
Neuroacanthocytosis
: VPS13A
PKAN
: PANK2
Hemochromatosis
3
General
Disorder of iron storage
Inappropriate increase in intestinal iron absorption
Deposition of iron in parenchymal cells
Several hereditary causes
Common adult form: HFE
with C282Y mutation; Recessive
Clinical
Onset
Age: Midlife
Symptoms: Fatigue, Abdominal Pain
Organ damage
Liver: Cirrhosis; Hepatomas
Pancreas (Diabetes)
Joints: Arthritis
Pituitary:
Hypogonadotropic hypogonadism
Cardiac: Cardiomyopathy
Skin: Pigmentation
Polyneuropathies
Frequency (26%)
Sensory loss
Type
Large or Small fiber
Axon loss
May be associated with diabetes
Myopathy
Objective features: Rare
Associated with hemodialysis
Proximal weakness
Discomfort: Cramps, Fatigue & Pain
Hemosiderin
deposits
Laboratory
Serum ferretin: High
Treatment: Removal of iron by phlebotomy or erythrocytapheresis
Retinitis Pigmentosa + Myopathy
6
●
Retinol dehydrogenase 11 (RDH11)
; Chromosome 14q24.1; Recessive
Epidemiology: 1 Chinese patient
Genetics
Mutations: Leu313Pro; Splice site (c.75-3C>A)
Allelic disorder: Retinal dystrophy, Juvenile cataracts, Short stature (RDJCSS)
RDH11 protein
11-cis-retinol dehydrogenase
Role in retinoid cycle
Clinical
Onset: 1 year; Delayed walking
Intellectual delay
Eye
Cataracts: Binocular
Retinitis pigmentosa: Visual loss
Weakness: Limbs
Laboratory
Serum CK: 441 to 618
Muscle pathology
Fiber sizes: Varied
Internal architcture: Linearization
Ultrastructure: Focal myofilament pathology
RDH11: Present on sarcolemma, not cytoplasm
Dyserythropoietic Anemia +
Centronuclear
Myopathy, Canine (DAMS)
7
●
EH Domain-binding protein-like 1 (EHPB1L1)
; Chromosome 11q13.1; Recessive
Epidemiology: Labrador Retrievers & English Springer Spaniels
Genetics
Mutations: Stop; c.388C>T, c.3120delC; Homozygous
Allelic disorder: Recurrent fetal death in humans
EHPB1L1 protein
Actin cytoskeletal organization
Apical-directed transport in polarized epithelial cells
Membrane vesicles in endocytic recycling compartment
Through connections with Rab8 &
BIN1
-
Dynamin
complex
Clinical
Weakness
Temporal
Pelvic
Dysphagia
Megaesopagus
Trismus
Exercise intolerance
Laboratory
Anemia: Microcytic, Hypochromic; Metarubricytosis; Target cells; Acanthocytes
Muscle
Central nuclei
Fiber sizes: Varied
COX & SDH: Dark central staining of muscle fibers
Lipid & Connective tissue increased
Serum CK: Normal
Return to
Neuromuscular Home Page
References
1. Neurology 2000;54:1011
2. Muscle Nerve 2004;30:569–577
3.
J Neurol 2010; Online April
4.
Clin Neurophysiol 2021;132:3125-3135
5.
Muscle Nerve 2022 Jan 5
6.
Clin Genet 2022 Jan 6
7.
Genes 2022;13:1533
,
Genes 2022;13:1427
9/24/2022